Related Experiment Videos
Immune reactions in acute viral hepatitis
Clinical and Experimental Immunology
|April 1, 1975
Summary
Hepatitis A and B impair lymphocyte function, with a serum inhibitor present during acute illness. This immune defect persists long-term, potentially due to the hepatitis virus itself.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Hepatitis A and B are significant global health concerns.
- Immune system dysregulation is observed in viral hepatitis.
- Lymphocyte transformation assays are key indicators of immune function.
Purpose of the Study:
- To investigate the impact of hepatitis A and B on lymphocyte transformation.
- To identify factors contributing to impaired immune responses in hepatitis patients.
- To differentiate acute and chronic effects on cellular immunity.
Main Methods:
- Serial assessment of PHA-induced lymphocyte transformation in hepatitis patients.
- Analysis of serum autoantibodies, immunoglobulins, and complement levels.
- Investigation of serum inhibitors affecting lymphocyte response to PHA.
Main Results:
- Marked impairment of PHA-induced lymphocyte transformation during the first week of jaundice in both hepatitis A and B.
- Prolonged, less severe impairment observed for 6-10 weeks post-jaundice onset.
- Detection of a serum inhibitor of lymphocyte response during the acute phase, affecting both patient and normal lymphocytes.
- Partial restoration of PHA response upon washing lymphocytes, suggesting a serum factor's role in acute impairment.
- Protracted lymphocyte defect possibly induced by the hepatitis virus.
Conclusions:
- Hepatitis A and B acutely impair T-cell mediated immunity via serum factors.
- A persistent lymphocyte defect, likely virus-induced, contributes to long-term immune alterations.
- The study differentiates immediate serum-mediated effects from prolonged cellular dysfunction in viral hepatitis.